BridGene Biosciences is a biotechnology company focused on pioneering the next era of small molecule therapeutics. The company develops innovative platforms to discover and optimize novel drug candidates, aiming to address unmet medical needs across various disease areas.
Bridgenebiosciences is profiled on the APIs.io network. Tagged areas include Biotechnology, Drug Discovery, Small Molecules, Therapeutics, and Company.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: bridgenebiosciences
name: Bridgenebiosciences
description: BridGene Biosciences is a biotechnology company focused on pioneering the next era of small molecule therapeutics.
The company develops innovative platforms to discover and optimize novel drug candidates, aiming to address unmet medical
needs across various disease areas.
url: https://raw.githubusercontent.com/api-evangelist/bridgenebiosciences/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-10-05 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-10-05'
modified: '2026-10-05'
tags:
- Biotechnology
- Drug Discovery
- Small Molecules
- Therapeutics
- Company
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/bridgenebiosciences-hosts.yml
- type: Vendors
url: vendors/bridgenebiosciences-vendors.yml
- type: DomainSecurity
url: security/bridgenebiosciences-domain-security.yml
- type: Website
url: https://equityzen.com/company/bridgenebiosciences
apis: []
x-coverage:
state: blocked
reason: bot-challenge
method: derived
generated: '2026-10-05'
generator: derive-coverage.py (pre-flight evidence)
detail: the company's own front door answers a browser with an anti-bot challenge, so nothing behind it is reachable by
any reader
evidence:
- url: https://equityzen.com/company/bridgenebiosciences
status: 403
x-enrichment:
date: '2026-10-05'
status: enriched
artifacts_added: 4
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.